Survival rates for oral cancer patients have remained unchanged in the past several decades largely because of diagnosis at late stage and local recurrence after treatment. In retrospective studies, patterns of loss of heterozygosity (LOH) have been associated with risk of progression of oral premalignant lesions to cancer and disease recurrence. The objective of the current proposal is to evaluate the prognostic value of specific LOH patterns in combination with clinical and histological features to predict outcome for oral lesions within a longitudinal study. We have used the unique medical infrastructure in British Columbia to establish one of the largest cohort studies of precancer and cancer patients in order to systematically follow changes in clinical, pathological and molecular parameters over time. The proposed grant renewal will extend the follow-up time of the established cohort and will accrue additional patients to 200 oral cancer patients and 200 patients with primary oral dysplasia. It will also fund the collection of tissue samples (biopsies, scrapes, brushings) and the analysis of allelic loss in these specimens. This extension will allow for better longitudinal modeling of risk patterns, including temporal changes of clinical, pathological and molecular markers, and will provide a multi-faceted risk model with clinical application that can be used to manage oral lesions and cancers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE013124-04A1
Application #
6580189
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Shirazi, Yasaman
Project Start
1999-09-24
Project End
2008-02-29
Budget Start
2003-02-20
Budget End
2004-02-29
Support Year
4
Fiscal Year
2003
Total Cost
$378,478
Indirect Cost
Name
British Columbia Cancer Agency
Department
Type
DUNS #
209137736
City
Vancouver
State
BC
Country
Canada
Zip Code
V5 1-L3
Rock, L D; Rosin, M P; Zhang, L et al. (2018) Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine. Oral Oncol 78:119-125
Zhang, Lewei; Lubpairee, Tarinee; Laronde, Denise M et al. (2016) Should severe epithelial dysplasia be treated? Oral Oncol 60:125-9
Baik, Jonathan; Ye, Qian; Zhang, Lewei et al. (2014) Automated classification of oral premalignant lesions using image cytometry and Random Forests-based algorithms. Cell Oncol (Dordr) 37:193-202
Laronde, Denise M; Williams, P M; Hislop, T G et al. (2014) Decision making on detection and triage of oral mucosa lesions in community dental practices: screening decisions and referral. Community Dent Oral Epidemiol 42:375-84
Martinez, Victor D; MacAulay, Calum E; Guillaud, Martial et al. (2014) Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities. Oral Oncol 50:1123-30
Laronde, Denise M; Williams, P M; Hislop, T G et al. (2014) Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices. J Oral Pathol Med 43:7-13
Rosin, Miriam P; Zhang, Lewei; Mao, Li (2013) Predicting progression of oral dysplasia--response. Cancer Prev Res (Phila) 6:616
Zhang, Lewei; Poh, Catherine F; Williams, Michele et al. (2012) Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila) 5:1081-9
Poh, Catherine F; MacAulay, Calum E; Laronde, Denise M et al. (2011) Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era. Periodontol 2000 57:73-88
Gibb, Ewan A; Enfield, Katey S S; Stewart, Greg L et al. (2011) Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral Oncol 47:1055-61

Showing the most recent 10 out of 36 publications